Daniel G. Kaye
At a glance: Daniel G. Kaye is Director at CME Group (CME). Their latest SEC Form 4, filed Nov 10, 2026, reported a sale of $162K. On file: 0 purchase lines ($0) and 1 sale line ($162K).
Disclosed holdings: about $1.3M of CME stock: 4,313 shares reported on their latest Form 4 (filed Nov 10, 2026), valued at the Nov 20, 2026 close of $311.15. This counts only CME shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Cme Group Inc. (CME)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Daniel G. Kaye's InsiderPrint
3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $47K a trade.
- Bump outward: a purchase (2)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Garen G. BohlinDirector · COLL · 100% match
- Steven A. KassDirector · SNEX · 100% match
- Jeanmarie F. DesmondDirector · IPGP · 99% match
- Daniel M. JuniusDirector · IDXX · 99% match
- Brett D. FulkAcnb Bank Evp · ACNB · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow Daniel G. Kaye
Get one email when Daniel G. Kaye files a new purchase or sale. Free.
At most one email a day about Daniel G. Kaye, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.